Stock Screener App

무료 -

설치하다

34.42

3.94% -1.41

after-market

시간 외 거래: 34.38 -0.04 -0.12%

First Tracks Biotherapeutics Inc (TRAX)

개요 뉴스 가격 이력 토론 예측

First Tracks Biotherapeutics Inc 주식(TRAX)의 최신 뉴스

First Tracks Biotherapeutics Inc Balance Sheet – MUN:B43 - TradingView

First Tracks Biotherapeutics Inc Cash Flow – MUN:B43 - TradingView

Debt to assets ratio of First Tracks Biotherapeutics Inc – GETTEX:A428R1 - TradingView

First Tracks Biotherapeutics Inc Cash Flow – GETTEX:A428R1 - TradingView

State Street Corp Buys 1,512,896 Shares of First Tracks Biotherapeutics $TRAX - MarketBeat

AnaptysBio : Annual Transition Report (Form 10-KT) - marketscreener.com

Spin-off leaves AnaptysBio (ANAB) a lean royalty firm - Stock Titan

Anaptys Announces Second Quarter and Transitional Fiscal - GlobeNewswire

Why Did CRCL Stock Lose Steam? Wall Street Split On Circle’s Banking Win - Stocktwits

First Tracks Biotherapeutics Inc (TRAX) Stock Price, Quote, News & History - Benzinga

This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Evercore Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $65 - Moomoo

John Orwin (TRAX) lifts direct stake to 17,995 shares - Stock Titan

First Tracks Biotherapeutics (NASDAQ:TRAX) Stock Rating Upgraded by Guggenheim - MarketBeat

Why is First Tracks Biotherapeutics stock rallying today? By Investing.com - Investing.com Canada

First Tracks Biotherapeutics stock rises on Guggenheim buy rating - Investing.com

First Tracks Biotherapeutics stock rises on Guggenheim buy rating By Investing.com - Investing.com Canada

Guggenheim initiates coverage of First Tracks with Buy rating, $100 price target - TradingView

Guggenheim initiates First Tracks stock with buy on autoimmune drug potential - Investing.com Canada

First Tracks Biotherapeutics Inc Actuals & Estimates (NASDAQ:TRAX) - TradingView

Basic earnings per share (basic EPS) of First Tracks Biotherapeutics Inc – FWB:B43 - TradingView

First Tracks Biotherapeutics Inc Cash Flow – FWB:B43 - TradingView

ETFs Investing in First Tracks Biotherapeutics Inc Stocks - TradingView

First Tracks Biotherapeutics at wells fargo healthcare conference: data loom By Investing.com - Investing.com South Africa

First Tracks Biotherapeutics Insider Ware J. Anthony Sells 39,265 Shares at $44.78 Following Option Exercise - Kalkine Media

TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC

First Tracks Biotherapeutics Director Sold Shares Worth Over $1.7M - TradingView

First Tracks Biotherapeutics (TRAX) director sells shares after option exercise - Stock Titan

H.C. Wainwright Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $57 - Moomoo

TRAX Reiterates by First Tracks -- Price Target Maintained at $5 - GuruFocus

Long term debt to total assets ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Which stocks are gapping on Wednesday? - ChartMill

Dell, Gitlab surge 11-14% on strong Q2 results; Sirius XM rises - scanx.trade

Cash flow from operating activities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

EBIT per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Revenue per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Tangible book value per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Return on assets % of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Price to book ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com

Total debt of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

After tax other income/expense of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

First Tracks Biotherapeutics Announces Participation in September Investor Conferences - Yahoo Finance

Non-controlling/minority interest of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Total liabilities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Taxes of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Diluted shares outstanding of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Total operating expenses of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Diluted earnings per share (diluted EPS) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com

First Tracks Biotherapeutics, Inc. Revenue Breakdown – NASDAQ:TRAX - TradingView

Total revenue of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com

Dilution adjustment of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Price to cash flow ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

CapEx per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Number of shareholders of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Enterprise value to EBITDA forward of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - tradingview.com

Net debt of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Gross profit of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

EBIT of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Net current asset value per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Free cash flow of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Total liabilities & shareholders' equities of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Non-operating income (total) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Enterprise value to EBITDA ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

EBITDA per share of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Enterprise value to EBIT forward of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Operating expenses (excl. COGS) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Discontinued operations of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

Diluted net income available to common stockholders of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView

AnaptysBio, Inc. (ANAB) Earnings Preview: The First Full Royalty-Model Quarter Matters More Than the Headline EPS - AlphaStreet

J.P. Morgan Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Raises Target Price to $65 - Moomoo

Piper Sandler Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Maintains Target Price $95 - Moomoo

symbol__ Stock Quote Price and Forecast - CNN

First Tracks Biotherapeutics CBO Benjamin Stone Receives 60,492 Performance Stock Units - Kalkine Media

INSM

$117.83

3.06%

ROIV

$35.80

0.91%

RPRX

$58.21

0.14%

ALNY

$255.96

2.55%

ONC

$360.85

0.24%

RVMD

$204.97

2.56%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개